VFA
REGN icon

Virtus Fund Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Virtus Fund Advisers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$936K Buy
+2,490
New +$1.01M 0.01% 303
2015
Q1 		– Sell
-86
Closed -$35K – 1025
2014
Q4 		$35K Hold
86
– – ﹤0.01% 852
2014
Q3 		$31K Sell
86
-702
-89% -$235K ﹤0.01% 890
2014
Q2 		$223K Buy
+788
New +$234K ﹤0.01% 938

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Virtus Fund Advisers's REGN Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2017: 2,490 shares worth $936K. The stake represents 0.01% of the portfolio and ranks #303 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in REGN as recently as Q4 2014.

Virtus Fund Advisers first reported a position in REGN in Q2 2014 and has held it in 4 quarters since. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • Virtus Fund Advisers held 2,490 shares of Regeneron Pharmaceuticals worth $936K as of Q4 2017.
  • Regeneron Pharmaceuticals was a new Virtus Fund Advisers position in Q4 2017.
  • Regeneron Pharmaceuticals made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #303 holding.
  • Virtus Fund Advisers first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 4 quarters since.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.